» Articles » PMID: 10028074

Mayaro Virus Disease: an Emerging Mosquito-borne Zoonosis in Tropical South America

Overview
Journal Clin Infect Dis
Date 1999 Feb 24
PMID 10028074
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

This report describes the clinical, laboratory, and epidemiological findings on 27 cases of Mayaro virus (MV) disease, an emerging mosquito-borne viral illness that is endemic in rural areas of tropical South America. MV disease is a nonfatal, dengue-like illness characterized by fever, chills, headache, eye pain, generalized myalgia, arthralgia, diarrhea, vomiting, and rash of 3-5 days' duration. Severe joint pain is a prominent feature of this illness; the arthralgia sometimes persists for months and can be quite incapacitating. Cases of two visitors from the United States, who developed MV disease during visits to eastern Peru, are reported. MV disease and dengue are difficult to differentiate clinically.

Citing Articles

Interaction of the endogenous antibody response with activating FcγRs enhance control of Mayaro virus through monocytes.

Dunagan M, Dabilla N, McNinch C, Brenchley J, Dolan P, Fox J PLoS Pathog. 2025; 21(2):e1012944.

PMID: 39993025 PMC: 11884725. DOI: 10.1371/journal.ppat.1012944.


Unraveling the Nanomechanical and Vibrational Properties of the Mayaro Virus.

Franca A, Diniz-Filho J, Dos Santos C, Durco Coimbra L, Marques R, Barbosa L ACS Omega. 2024; 9(49):48397-48404.

PMID: 39676942 PMC: 11635520. DOI: 10.1021/acsomega.4c06749.


Mayaro Virus: An Emerging Alphavirus in the Americas.

Wei L, Tom R, Kim Y Viruses. 2024; 16(8).

PMID: 39205271 PMC: 11359717. DOI: 10.3390/v16081297.


Chikungunya and Mayaro Viruses Induce Chronic Skeletal Muscle Atrophy Triggered by Pro-Inflammatory and Oxidative Response.

da Silva M, Figueiredo C, Neris R, Guimaraes-Andrade I, Gavino-Leopoldino D, Miler-da-Silva L Int J Mol Sci. 2024; 25(16).

PMID: 39201595 PMC: 11354814. DOI: 10.3390/ijms25168909.


Activating FcγRs on monocytes are necessary for optimal Mayaro virus clearance.

Dunagan M, Dabilla N, McNinch C, Brenchley J, Dolan P, Fox J bioRxiv. 2024; .

PMID: 39149309 PMC: 11326306. DOI: 10.1101/2024.07.23.604823.